Quantitative color mapping of the arterial enhancement fraction in patients with diffuse liver disease

American Journal of Roentgenology

Volumn 197, Issue 4, 2011, Pages 876-883

  Kang, Sung Eun ^a   Lee, Jeong Min ^a   Klotz, Ernst ^b   Kim, Kyung Won ^a   Kim, Jung Hoon ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University Hospital   (South Korea)

^b SIEMENS AG   (Germany)

Author keywords

Arterial enhancement fraction; Diffuse liver disease; Liver perfusion; Multiphasic CT; Quantitative imaging

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; COLOR MAPPING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEMODYNAMIC MONITORING; HUMAN; IMAGE ENHANCEMENT; IMAGING AND DISPLAY; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER DISEASE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CASE-CONTROL STUDIES; COLOR; CONTRAST MEDIA; FEMALE; HUMANS; IOHEXOL; LIVER CIRCULATION; LIVER DISEASES; MALE; MIDDLE AGED; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053250931     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5943     Document Type: Article

References (28)

1. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99:1160-1174 (Pubitemid 38917824)
2. Baron RL, Peterson MS. From the RSNA refresher courses. RadioGraphics 2001; 21:S117-S132
3. Lim YS, Kim W. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 2008; 12:733-746
4. Guha IN, Rosenberg WM. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clin Liver Dis 2008; 12: 883-900
5. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T. Cirrhosis: modified caudateright lobe ratio. Radiology 2002; 224:769-774 (Pubitemid 34919811)
6. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005; 234: 661-673 (Pubitemid 40250807)
7. Gulberg V, Haag K, Rossle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002; 35:630-634 (Pubitemid 34183968)
8. Huet PM, Pomier-Layrargues G, Villeneuve JP, Varin F, Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis 1986; 6:277-286
9. Lebrec D, Nouel O, Bernuau J, Rueff B, Benhamou J. Portal hypertension in fulminant viral hepatitis. Gut 1980; 21:962-964 (Pubitemid 11213471)
10. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996; 16:379-388 (Pubitemid 27074780)
11. Chen ML, Zeng QY, Huo JW, Yin XM, Li BP, Liu JX. Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography. World J Gastroenterol 2009; 15: 3532-3537
12. Ronot M, Asselah T, Paradis V, et al. Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 2010; 256:135-142
13. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue? Initial experience. Radiology 2007; 243:736-743 (Pubitemid 46799427)
14. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004; 11:215-223 (Pubitemid 38140292)
15. Kim KW, Lee JM, Klotz E, et al. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology 2009; 250:425-434
16. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. Part II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000; 46:2050-2068
17. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46:912-921 (Pubitemid 47436137)
18. Child CG III, Turcotte JG. Surgery and portal hypertension. In: Child CG III, ed. The liver and portal hypertension. Philadelphia. PA: Saunders, 1964:49-50
19. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649
20. Faugeras O, Hermosillo G. Flows of diffeomorphisms for multimodal image registration. In: 2002 IEEE International Symposium on Biomedical Imaging: proceedings. Piscataway, NJ: IEEE, 2002:7-8
21. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg 1999; 16: 459-467 (Pubitemid 30072153)
22. Martinez-Hernandez A. The hepatic extracellular matrix. Part II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest 1985; 53:166-186 (Pubitemid 15049008)
23. Hagiwara M, Rusinek H, Lee VS, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 2008; 246:926-934
24. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188:405-411 (Pubitemid 23216260)
25. van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR 2001; 176:667-673 (Pubitemid 32181963)
26. Kim KW, Lee JM, Kim JH, et al. CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT. AJR 2011; 196:102-108
27. Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radio- Graphics 2009; 29:1591-1614
28. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci 1998; 43:1311-1316 (Pubitemid 28272568)